Stock market today: S&P 500 climbs as health care, tech gain; Nvidia earnings loom
Aurora Cannabis (TSX:ACB) Inc. (NYSE:NASDAQ:ACB) submitted a Form 6-K report to the U.S. Securities and Exchange Commission (SEC) on Tuesday. The filing, dated June 3, 2025, was signed by CEO Miguel Martin and pertains to the company’s activities for the month of June.
The report, filed under the Securities Exchange Act of 1934, includes a news release as an exhibit. Aurora Cannabis, a company classified under the medicinal chemicals and botanical products sector, is headquartered in Edmonton, Alberta, Canada. The filing indicates that the company is incorporated in an unspecified region labeled as "A1."
This submission is part of Aurora Cannabis’s routine disclosure obligations as a foreign private issuer. The company continues to file annual reports under Form 40-F, as indicated in the document.
The filing does not provide specific details about the company’s financial performance or strategic initiatives, focusing instead on regulatory compliance. Investors and stakeholders may find more detailed information in the accompanying news release, which is listed as Exhibit 99.1 in the report.
This summary is based on the information provided in the SEC filing.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.